Virios Therapeutics (VIRI) Short Interest Ratio & Short Volume $2.60 +0.75 (+40.54%) (As of 11/19/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends Virios Therapeutics Short Interest DataVirios Therapeutics (VIRI) has a short interest of 469,900 shares. This marks a -19.02% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 1.05 million shares to cover all short positions.Current Short Interest469,900 sharesPrevious Short Interest580,300 sharesChange Vs. Previous Month-19.02%Dollar Volume Sold Short$91,583.51Short Interest Ratio0.5 Days to CoverLast Record DateSeptember 15, 2024Outstanding Shares19,258,000 sharesPercentage of Shares Shorted2.44%Today's Trading Volume637,000 sharesAverage Trading Volume1,049,645 sharesToday's Volume Vs. Average61% Short Selling Virios Therapeutics? Sign up to receive the latest short interest report for Virios Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVIRI Short Interest Over TimeVIRI Days to Cover Over TimeVIRI Percentage of Float Shorted Over Time Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Virios Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/2024469,900 shares $91,583.51 -19.0%N/A0.5 $0.19 8/31/2024580,300 shares $112,578.20 +77.4%N/A0.5 $0.19 8/15/2024327,200 shares $61,775.36 -43.6%N/A0.2 $0.19 7/31/2024579,800 shares $122,337.80 -33.9%N/A0.4 $0.21 7/15/2024877,700 shares $214,246.57 +181.1%N/A0.6 $0.24 6/30/2024312,200 shares $67,123.00 -45.3%N/A0.3 $0.22 Get the Latest News and Ratings for VIRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 6/15/2024570,300 shares $135,845.46 +70.1%N/A0.5 $0.24 5/31/2024335,300 shares $72,156.56 +233.6%N/A0.3 $0.22 5/15/2024100,500 shares $40,853.25 -57.9%N/A0.2 $0.41 4/30/2024238,500 shares $108,016.65 +11.2%N/A0.8 $0.45 4/15/2024214,500 shares $101,029.50 -1.4%N/A0.7 $0.47 3/31/2024217,500 shares $104,204.25 +27.8%N/A0.6 $0.48 3/15/2024170,200 shares $54,123.60 +76.9%N/A0.5 $0.32 2/29/202496,200 shares $35,690.20 -36.8%N/A0.4 $0.37 2/15/2024152,300 shares $58,787.80 +67.4%N/A0.6 $0.39 1/31/202491,000 shares $37,310.00 -59.5%N/A0.3 $0.41 1/15/2024224,900 shares $170,699.10 +1.5%N/A0.5 $0.76 12/31/2023221,600 shares $127,420.00 -12.6%N/A0.5 $0.58 12/15/2023253,400 shares $169,651.30 -13.0%N/A0.6 $0.67 11/30/2023291,100 shares $165,635.90 -35.8%N/A0.7 $0.57 11/15/2023453,700 shares $333,197.28 +308.7%N/A1 $0.73 10/31/2023111,000 shares $61,050.00 -42.7%N/A0.2 $0.55 10/15/2023193,800 shares $154,071.00 -30.4%N/A0.5 $0.80 9/30/2023278,500 shares $257,556.80 -33.4%N/A0.5 $0.92 9/15/2023418,400 shares $435,136.00 -10.0%N/A0.7 $1.04 8/31/2023465,100 shares $511,610.00 -17.9%N/A0.7 $1.10 8/15/2023566,300 shares $577,626.00 -4.0%N/A0.7 $1.02 7/31/2023589,800 shares $1.12 million +16.2%N/A0.8 $1.90 7/15/2023507,600 shares $1.23 million +52.1%N/A0.2 $2.42 6/30/2023333,700 shares $460,506.00 -36.4%N/A0.1 $1.38 6/15/2023524,500 shares $970,325.00 +26.6%N/A0.2 $1.85 5/31/2023414,300 shares $712,596.00 +26.5%N/A0.1 $1.72 5/15/2023327,500 shares $337,325.00 -68.8%N/A0.1 $1.03 4/30/20231,050,000 shares $766,500.00 +95.9%N/A0.4 $0.73 4/15/2023536,100 shares $364,548.00 +45.3%N/A0.2 $0.68 3/31/2023368,900 shares $135,570.75 +0.0%N/A0.6 $0.37 3/15/2023368,800 shares $111,857.04 +52.5%N/A0.8 $0.30 2/28/2023241,900 shares $72,570.00 +18.3%N/A0.6 $0.30 2/15/2023204,500 shares $69,100.55 -23.6%N/A0.6 $0.34 1/31/2023267,700 shares $82,612.22 +25.6%N/A0.8 $0.31JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 1/15/2023213,100 shares $59,028.70 +4.0%N/A0.7 $0.28 12/30/2022205,000 shares $48,380.00 -42.5%N/A0.7 $0.24 12/15/2022356,400 shares $92,664.00 +20.8%N/A1.1 $0.26 11/30/2022295,100 shares $85,579.00 -33.2%N/A0.4 $0.29 11/15/2022441,500 shares $136,865.00 +55.7%N/A0.6 $0.31 10/31/2022283,600 shares $77,990.00 -34.4%N/A0.4 $0.28 10/15/2022432,600 shares $154,438.20 +8.7%N/A0.7 $0.36 9/30/2022398,100 shares $151,477.05 +526.9%4.8%0.7 $0.38 9/15/202263,500 shares $492,760.00 +18.0%0.8%0.1 $7.76 8/31/202253,800 shares $380,366.00 +6.8%1.0%2.2 $7.07 8/15/202250,400 shares $422,352.00 +5.2%0.9%2.2 $8.38 7/31/202247,900 shares $335,300.00 +5.7%0.9%2.8 $7.00 7/15/202245,300 shares $256,851.00 -4.2%0.8%2.6 $5.67 6/30/202247,300 shares $200,079.00 -1.5%0.9%3.1 $4.23 6/15/202248,000 shares $193,920.00 +5.7%0.9%2.7 $4.04 5/31/202245,400 shares $194,766.00 +1.3%0.9%2.4 $4.29 5/15/202244,800 shares $158,144.00 +5.7%0.9%2.2 $3.53 4/30/202242,400 shares $170,024.00 -7.6%0.8%2.4 $4.01 4/15/202245,900 shares $195,593.67 -1.7%0.9%2.3 $4.26 3/31/202246,700 shares $209,216.00 -6.6%0.9%2 $4.48 3/15/202250,000 shares $250,500.00 +1.8%1.0%2.1 $5.01 2/28/202249,100 shares $277,906.00 -9.2%0.9%2.1 $5.66 2/15/202254,100 shares $342,994.00 -11.6%1.0%2.2 $6.34 1/31/202261,200 shares $391,680.00 -4.4%1.2%2.1 $6.40 1/15/202264,000 shares $407,040.00 -1.2%1.2%1.9 $6.36 12/31/202164,800 shares $331,776.00 -16.9%1.2%2.1 $5.12 12/15/202178,000 shares $383,760.00 -2.1%1.5%2.7 $4.92 11/30/202179,700 shares $434,365.00 -14.9%1.5%2.8 $5.45 11/15/202193,600 shares $509,184.00 +34.1%1.8%3 $5.44 10/29/202169,800 shares $325,966.00 -0.6%1.3%2.3 $4.67 10/15/202170,200 shares $329,940.00 -6.9%1.3%2.9 $4.70 9/30/202175,400 shares $398,866.00 -2.8%1.4%2.3 $5.29 9/15/202177,600 shares $426,800.00 -6.5%1.1%2.1 $5.50 8/31/202183,000 shares $419,980.00 +11.7%4.0%1 $5.06 8/13/202174,300 shares $375,215.00 -3.3%3.5%0.8 $5.05 7/30/202176,800 shares $456,960.00 +1.1%1.5%0.5 $5.95 7/15/202176,000 shares $464,360.00 -7.0%1.4%0.5 $6.11 6/30/202181,700 shares $513,893.00 -16.2%1.5%0.5 $6.29 6/15/202197,500 shares $555,750.00 +0.6%1.8%0.6 $5.70 5/28/202196,900 shares $508,725.00 -0.5%1.8%0.8 $5.25 5/14/202197,400 shares $458,754.00 -10.8%1.4%0.7 $4.71 4/30/2021109,200 shares $634,452.00 -16.4%1.5%1 $5.81 4/15/2021130,600 shares $770,540.00 +1.7%1.9%0.8 $5.90 3/31/2021128,400 shares $731,880.00 +9.6%1.8%0.6 $5.70 3/15/2021117,200 shares $772,348.00 +57.5%1.8%0.3 $6.59 2/26/202174,400 shares $471,696.00 +3.9%1.1%0.1 $6.34 2/12/202171,600 shares $539,148.00 +24.1%1.1%0.1 $7.53 1/29/202157,700 shares $413,709.00 +18.5%0.9%0.1 $7.17 1/15/202148,700 shares $406,158.00 No Change0.7%0 $8.34 VIRI Short Interest - Frequently Asked Questions What is Virios Therapeutics' current short interest? Short interest is the volume of Virios Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 469,900 shares of VIRI short. Learn More on Virios Therapeutics' current short interest. Is Virios Therapeutics' short interest increasing or decreasing? Virios Therapeutics saw a decrease in short interest in September. As of September 15th, there was short interest totaling 469,900 shares, a decrease of 19.0% from the previous total of 580,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Virios Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Virios Therapeutics: Neurogene Inc. (8.89%), Lexeo Therapeutics, Inc. (9.82%), Editas Medicine, Inc. (20.88%), Corbus Pharmaceuticals Holdings, Inc. (20.17%), Opthea Limited (0.13%), Enanta Pharmaceuticals, Inc. (17.46%), ADC Therapeutics SA (3.28%), Compass Therapeutics, Inc. (2.09%), Heron Therapeutics, Inc. (18.94%), Inozyme Pharma, Inc. (7.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short Virios Therapeutics stock? Short selling VIRI is an investing strategy that aims to generate trading profit from Virios Therapeutics as its price is falling. VIRI shares are trading up $0.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Virios Therapeutics? A short squeeze for Virios Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VIRI, which in turn drives the price of the stock up even further. How often is Virios Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIRI, twice per month. The most recent reporting period available is September, 15 2024. More Short Interest Resources from MarketBeat Related Companies NGNE Short Squeeze LXEO Short Squeeze EDIT Short Squeeze CRBP Short Squeeze OPT Short Squeeze ENTA Short Squeeze ADCT Short Squeeze CMPX Short Squeeze HRTX Short Squeeze INZY Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VIRI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virios Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virios Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIRI Stock Alerts